Oxford Square Capital Corp. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 4, 2025

(NasdaqGM:OXSQ),(NASDAQ:OXSQZ),(NASDAQ:OXSQG),(NASDAQ:OXSQH), GREENWICH, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) announced today that it will hold a conference call to discuss third quarter 2025 earnings on Tuesday, November 4, 2025 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-549-8228. There will be a […]

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Quantum Corporation (QMCO), Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA)

(NasdaqGM:QMCO),(NYSE:TROX),(NASDAQ:FLYE),(NASDAQ:SVRA), ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Quantum Corp. (QMCO) The shareholder class action lawsuit filed against Quantum Corporation (“Quantum” or the “Company”) (NASDAQ: QMCO) alleges that Defendants made materially false and/or

GrowGeneration Launches Dialed In(TM) Tri-Spec Under Canopy Light, a Breakthrough in Cannabis Flower Development and Yield Efficiency

(NASDAQ:GRWG), DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) — GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation's largest specialty hydroponic and organic gardening retailer, today announced the launch of its Dialed In(TM) Tri-Spec Under Canopy Light, a first-of-its-kind lighting solution engineered to boost lower-canopy flower development in commercial cannabis cultivation. The Dialed In(TM) Tri-Spec

Teads appoints Fernando Tassinari as Managing Director of LATAM to lead a new phase of regional growth and transformation

(NASDAQ:TEAD), SÃO PAULO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Teads (NASDAQ: TEAD), the omnichannel outcomes platform for the Open Internet, today announced the appointment of Fernando Tassinari as Managing Director of LATAM, effective immediately. This strategic leadership addition reinforces Teads' commitment to accelerating growth across key Latin American markets, expanding its branding and performance business,

INVESTOR ALERT: Investigation of Sonic Automotive, Inc. (SAH) Announced by Holzer & Holzer, LLC

(NYSE:SAH), ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Sonic Automotive, Inc. (“Sonic Automotive” or the “Company”) (NYSE: SAH) complied with federal securities laws. On October 23, 2025, Sonic Automotive announced financial results for the third quarter of 2025, revealing that net income decreased 37% year-over-year. The Company attributed

Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

(NASDAQ:EKSO), SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on October 28, 2025, it entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 769,490

Apollo and 8VC Partner to Accelerate the Next Wave of American Industrial Innovation

(NYSE:APO), NEW YORK and AUSTIN, Texas, Oct. 29, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) and 8VC today announced a strategic partnership to accelerate the American Industrial Renaissance through flexible capital solutions tailored to high-growth companies. Through this collaboration, Apollo and 8VC intend to deploy several billion dollars to support the work of technology companies

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

(NASDAQ:OPK),(NASDAQ:REGN), Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collaboration agreement with

Magnite to Participate in Upcoming Financial Conferences

(NASDAQ:MGNI), NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate in the following financial conferences: Seaport Virtual TMT Conference on Monday, November 17 Craig-Hallum Alpha Select Conference in New York City on Tuesday, November 18 Wells Fargo

Immutep Quarterly Activities Report Q1 FY26

(NasdaqGM:IMMP),(AUST:IMM.AX), Media Release Pivotal TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countries Trial in Progress poster for TACTI-004 presented at the World Conference on Lung Cancer (WCLC) 2025, where

Scroll to Top